Literature DB >> 24556002

Histopathologycal findings in the ovaries and uterus of albino female rats promoted by co-administration of synthetic steroids and nicotine.

Isabel Cristina Cherici Camargo1, Gabriel Adan Araújo Leite2, Tiago Pinto2, João Tadeu Ribeiro-Paes2.   

Abstract

The use of anabolic androgenic steroids is often associated with the use of other substances, licit or not, such as nicotine present in the tobacco. The present study investigated for the first time the effects of co-administration of synthetic steroids and nicotine on the ovarian and uterine tissue and fertility of adult female rats. Animals were submitted to treatment groups (n=16/group): nandrolone decanoate (ND; 7.5mg/kg BW/week); testosterone mixture (T; 7.5mg/kg BW/week); nicotine (N; 2.0mg/kg BW/day), and co-administration of ND/N, T/N and ND/T/N. The control group received saline solution daily. The injections were administered subcutaneously for 30 consecutive days. Results demonstrated that all androgenized rats exhibited estral acyclicity and there was suppression of reproductive capacity due to notable ovarian and uterine histological changes. Treatments promoted decrease (p<0.05) in the ovarian weight. Uterine weight increased (p<0.05) in the T and T/N groups, in comparison to control group. ND or T co-administered or not to nicotine promoted intense follicular degeneration, with formation of cysts in the ovaries. High levels of circulating androgens in the ND/T/N group induced the presence of ovarian sex cord-stromal tumors of Sertoli cell pattern. Androgenized females presented endometrial changes characterized by papilliferous or pleated luminal epithelium, oedematous and hemorrhagic stroma and presence of gland cysts. In conclusion, the co-administration of three drugs promoted atypical morphological pattern on the ovaries and uterus of female rats.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Histopathology; Nandrolone decanoate; Nicotine; Ovary; Rats; Testosterone mixture; Uterus

Mesh:

Substances:

Year:  2014        PMID: 24556002     DOI: 10.1016/j.etp.2014.01.005

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  6 in total

1.  The Molecular Quality and Mitochondrial Activity of Porcine Cumulus-Oocyte Complexes Are Affected by Their Exposure to Three Endocrine-Active Compounds under 3D In Vitro Maturation Conditions.

Authors:  Gabriela Gorczyca; Kamil Wartalski; Marek Romek; Marcin Samiec; Małgorzata Duda
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Effects of different doses of nandrolone decanoate on estrous cycle and ovarian tissue of rats after treatment and recovery periods.

Authors:  Vinícius Augusto Simão; Larissa Berloffa Belardin; Gabriel Adan Araújo Leite; Luiz Gustavo de Almeida Chuffa; Isabel Cristina Cherici Camargo
Journal:  Int J Exp Pathol       Date:  2015-11-17       Impact factor: 1.925

3.  Histopathological changes in androgenized ovaries are recovered by melatonin treatment.

Authors:  Bianca R de Souza; Luiz Gustavo de Almeida Chuffa; Vinícius Augusto Simão; Isabel C C Camargo
Journal:  Int J Exp Pathol       Date:  2018-08       Impact factor: 1.925

4.  Effect of multiple doses of N-methyl-N-nitrosourea, an end product of methylguanidine (found in processed food), on the fertility of female Swiss albino mice.

Authors:  Raghuram Kandimalla; Momita Das; Swarnali Bhattacharjee; Paramita Choudhury; Rajlakshmi Devi; Narayan C Talukdar; Suman Kumar Samanta
Journal:  Heliyon       Date:  2021-04-12

5.  The impact of nandrolone decanoate administration on ovarian and uterine tissues in rat: Luteinizing hormone profile, histopathological and morphometric assessment.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2017-08-26       Impact factor: 4.219

6.  The non-preventive effects of human menopausal gonadotropins on ovarian tissues in Nandrolone decanoate-treated female rats: A histochemical and ultra-structural study.

Authors:  Fakhroddin Mesbah; Hossein Bordbar; Tahereh Talaei Khozani; Farzaneh Dehghani; Hossein Mirkhani
Journal:  Int J Reprod Biomed       Date:  2018-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.